AN UNBIASED VIEW OF MBL77

Not all individuals with CLL involve therapy. In spite of all recent developments, the iwCLL even now recommends watchful observation for people with asymptomatic sickness.86 This suggestion is based on a minimum of two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103